This is a multiple sclerosis treatment discovered by a British woman called Cari Loder. It is said to be effective against fatigue, depression and ataxia.
At present details of the treatment are preliminary and secret, but, unlike many alternative therapies, it is undergoing clinical trials in the UK by Scotia Pharmaceuticals of New Zealand. These trials were due to be completed in late 1999, and results are due to be announced soon.
The treatment seems to be a triple-drug regime comprising Lofepramine (a tricyclic antidepressant), L-pheynlalanine (an amino acid) and vitamin B12. Dosages are available in the link sites below.
Until more details are released it is not possible comment further on its efficacy.
Cari Loder treatment links:
The Cari Loder treatment
The Patent Application
MS Only Q&A